An open trial of a Visnadine emulgel topical application in postmenopausal superficial dyspareunia: daily vs. on-demand use
Minerva Ginecol
.
2020 Feb;72(1):59-60.
doi: 10.23736/S0026-4784.19.04402-2.
Epub 2019 Sep 20.
Authors
Alberto Caputo
1
,
Adele Sparavigna
2
,
Alice Natoli
3
,
Clara Mandelli
4
Affiliations
1
IES (Istituto di Evoluzione Sessuale), Milan, Italy - acaputo@ies.milano.it.
2
Derming Institute of Clinical Research and Bioengineering, Milan, Italy.
3
IES (Istituto di Evoluzione Sessuale), Milan, Italy.
4
AlmaMed, Milan, Italy.
PMID:
31560182
DOI:
10.23736/S0026-4784.19.04402-2
No abstract available
Publication types
Clinical Trial
Letter
MeSH terms
Aged
Chromans / administration & dosage*
Coitus
Drug Administration Schedule
Dyspareunia / drug therapy*
Female
Humans
Middle Aged
Substances
Chromans
visnadin